Boston Scientific recalls 48,000 pacemakers

Boston Scientific Corp. (NYSE: BSX) has recalled about a decade’s worth of its Ingenio pacemakers, citing the risk that the products might permanently go into a backup setting called "safety mode" and lose their ability to pace properly. Read More

Read More

Opinion: Don’t tax away Mass. leadership in medtech

Opinion: Boston Scientific’s president of endoscopy writes that government policies have enabled the medtech giant to reinvest profits in multiple areas of innovation. "Patients cannot benefit from bets we don’t make. Read More

Read More